Acorai Funding Round

11/8/2023

Venture Equity

$2,458,000

Undisclosed

The company intends to use the funds to accelerate the progress of its goals, which are focused on clinical validation and regulatory submissions to enable commercialization.

Private & Independent

Medical Devices & Instruments

C/o HETCH AB Redaregatan 48
Helsingborg, 25236
SW

Acorai is developing a device for heart failure management through non-invasive intracardiac pressure monitoring (ICPM), to help reduce hospitalizations and readmissions. Our product, The Acorai Heart Monitor, can monitor mean pulmonary artery pressure (mPAP) non-invasively through a machine learning analysis of pressure dynamics in acoustics,vibratory and waveform data. Our technology show compelling precision, has a low-risk clinical and regulatory pathway, a low dependence on reimbursement and a fast track to commercialization. With a team with more than 50 years of industry experience, we can help heart failure patients live longer, healthier, and less uncertain lives.